Skip to main navigation

Corporate
Healthcare Professionals
Patients

Health Policy Resources
Contact Us

About Axonics
- Who We Are
- Leadership
Investor Relations
Careers
Contact Us

News Releases

News Releases

Year

Apr 26, 2022

Axonics® to Participate in BofA Securities 2022 Healthcare Conference

Apr 19, 2022

Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System

Apr 14, 2022

Axonics® to Report First Quarter 2022 Financial Results on May 5

Apr 04, 2022

Axonics® Launches Direct to Consumer Television Advertising Campaign

Mar 07, 2022

Axonics® Receives FDA Approval for Recharge-Free Sacral Neuromodulation System

Feb 24, 2022

Axonics® Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Feb 03, 2022

Axonics® to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24

Feb 01, 2022

Axonics® to Participate in SVB Leerink Virtual Healthcare Conference

Jan 25, 2022

New Study Finds More Than 60% of Adult Women in the U.S. Experience Urinary Incontinence

Jan 06, 2022

Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2021 Revenue

Pagination

First page
Previous page
Page 1
Current page 2

Print Page Email Page Email Alerts RSS Feeds

Questions?

We are here to help answer any questions you may have about the Axonics System and Therapy.

CONTACT US

Corporate Healthcare Professionals Patients

About Axonics Investor Relations Careers Contact Us

Contact Us

© 2020-2022 Axonics, Inc.
Privacy Policy | Terms of Use | Important Safety Information | Sitemap